KRAS and lung adenocarcinoma: Interestingly, as noted above, while components of the EFR3A complex were upregulated in KRAS mutation-positive pancreatic tumors, we nevertheless show synergy of C7 with sotorasib in KRASG12C-mutant human lung adenocarcinoma cell lines.